Abstract
Patients receiving autologous transplants for various malignancies generally experience an increased incidence of relapse compared with patients receiving unmanipulated allogeneic transplants. We initiated a protocol for IL-2 activation of peripheral blood stem cells (PBSC) for induction of in vitro and in vivo autologous graft-versus-tumor (GVT) activity in patients with breast cancer. In this study we analyzed the effects of 24 h of IL-2 incubation on the hematopoietic potential of PBSC from these patients. Cells collected by leukapheresis were first cryopreserved and stored in liquid nitrogen, then thawed rapidly and incubated with IL-2 in a serum-free system for 24 h, with samples analyzed before and after incubation. Although there was a significant drop in mononuclear cells (MNC) (from 4.5 to 3.7 x 108/kg) and CD34+ cells (from 12.3 to 7.5 x 106/kg) after 24 h in culture, there was no significant change in colony-forming units (CFU) (from 12.5 to 11.5 x 105/kg). Time to engraftment (neutrophils: < 0.5 x 109/l; platelets: > 20 x 109/l) was comparable to a cohort of similar patients receiving non-cultured PBSC transplants. These results indicate that mobilized frozen/thawed PBSC which have been cultured in IL-2 for 24 h retain adequate potential for hematopoietic reconsistution in this group of patients.
Original language | English (US) |
---|---|
Pages (from-to) | 521-525 |
Number of pages | 5 |
Journal | Bone Marrow Transplantation |
Volume | 18 |
Issue number | 3 |
State | Published - Sep 1 1996 |
Keywords
- Breast cancer
- Immunotherapy
- Interleukin-2
- PBSC
ASJC Scopus subject areas
- Hematology
- Transplantation